Immunosuppression. Convergence of drug action
- PMID: 2477712
- DOI: 10.1038/341692a0
Immunosuppression. Convergence of drug action
Similar articles
-
Immunosuppression. Binding by design.Nature. 1991 May 16;351(6323):185-6. doi: 10.1038/351185a0. Nature. 1991. PMID: 1710317 No abstract available.
-
Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.Chem Immunol. 1994;59:128-55. Chem Immunol. 1994. PMID: 7524531 No abstract available.
-
A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.Nature. 1989 Oct 26;341(6244):758-60. doi: 10.1038/341758a0. Nature. 1989. PMID: 2477715
-
Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.Biochem J. 1996 Mar 1;314 ( Pt 2)(Pt 2):361-85. Biochem J. 1996. PMID: 8670043 Free PMC article. Review. No abstract available.
-
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.Transplant Proc. 1991 Feb;23(1 Pt 2):914-9. Transplant Proc. 1991. PMID: 1703351 Review.
Cited by
-
Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.Immunology. 1990 Dec;71(4):551-5. Immunology. 1990. PMID: 1703987 Free PMC article.
-
Progress towards a molecular understanding of cyclosporin A-mediated immunosuppression.Clin Investig. 1992 Sep;70(9):773-9. doi: 10.1007/BF00180747. Clin Investig. 1992. PMID: 1450631 Review.
-
Composite somatotroph--ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma.Pituitary. 2001 Sep;4(4):215-21. doi: 10.1023/a:1020764013137. Pituitary. 2001. PMID: 12501971
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical